<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00715416</url>
  </required_header>
  <id_info>
    <org_study_id>1.1/2006</org_study_id>
    <nct_id>NCT00715416</nct_id>
  </id_info>
  <brief_title>PTA vs. Primary Stenting of SFA Using Self-Expandable Nitinol Stents</brief_title>
  <official_title>Balloon Angioplasty vs. Primary Stenting of Femoropopliteal Arteries Using Self-Expandable Nitinol Stents - a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vienna General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vienna General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators evaluated whether primary implantation of a self-expanding nitinol stent
      yielded anatomical and clinical benefits superior to those afforded by percutaneous
      transluminal angioplasty with optional secondary stenting.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2004</start_date>
  <completion_date type="Actual">February 2008</completion_date>
  <primary_completion_date type="Actual">February 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>occurrence of a &gt;50% restenosis at the treated segment at 6 months postintervention as determined by CTA (in-segment restenosis).</measure>
    <time_frame>3, 6, 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>ultrasound patency, clinical patency, target vessel and target lesion revascularization, cardiovascular events, quality of life at 3, 6 and 12 months after the procedure</measure>
    <time_frame>3, 6, 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">76</enrollment>
  <condition>Peripheral Vascular Diseases</condition>
  <condition>Intermittent Claudication</condition>
  <condition>Angioplasty</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>primary nitinol stent placement of superficial femoral artery lesions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>balloon angioplasty of superficial artery lesions with secondary stent placement in case of &gt;30% residual stenosis after the procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nitinol stent</intervention_name>
    <description>Interventions are performed percutaneously from either an antegrade or an over-the-bifurcation approach. After insertion of an 6 French sheath, 5000 IU of heparin are administered intra-arterially. After passage of the stenosis/occlusion with the guide wire, patients are randomized to either PTA or primary stent implantation. For standardized documentation of the lesion morphology and comparability during follow-up, a ruler is fixed at the patients thigh with the distal end exactly overlapping at the upper edge of the patella. As a bail-out procedure in the PTA group, stent placement is performed in cases with a residual stenosis of more than 30% in the worst view angiogram.</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Nitinol Stent Placement</intervention_name>
    <description>Balloon angioplasty compared to primary stent implantation for long segment superficial femoral artery lesions</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Product: peripheral stent system</other_name>
    <other_name>Type: ASTRON</other_name>
    <other_name>EC class: IIb</other_name>
    <other_name>Certificate number: G1 01 10 10275 193</other_name>
    <other_name>EC number: 0123</other_name>
    <other_name>Date of issue: 26.10.2001</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  symptomatic peripheral artery disease with severe intermittent claudication (Fontaine
             stage IIb)

          -  critical limb ischemia in patients with stenosis or occlusions originating in the SFA

          -  up to 25 cm length of stenosis/occlusion

        Exclusion Criteria:

          -  previous bypass surgery at the site of treatment

          -  history of intolerance of anti-platelet therapy

          -  adverse reaction to heparin

          -  bleeding diathesis

          -  creatinine &gt;2.5 mg/dL

          -  active bacterial infection

          -  allergy to contrast media

          -  previous stent placement at or immediately adjacent to the target lesion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Schilliger, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>General Hospital of Vienna, Department of Angiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Martin Schillinger, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>General Hospital of Vienna</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <reference>
    <citation>Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, Schlager O, Cejna M, Lammer J, Minar E. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006 May 4;354(18):1879-88.</citation>
    <PMID>16672699</PMID>
  </reference>
  <verification_date>January 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 11, 2008</study_first_submitted>
  <study_first_submitted_qc>July 11, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 15, 2008</study_first_posted>
  <last_update_submitted>July 11, 2008</last_update_submitted>
  <last_update_submitted_qc>July 11, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 15, 2008</last_update_posted>
  <responsible_party>
    <name_title>Prof. Martin Schillinger</name_title>
    <organization>General Hospital of Vienna</organization>
  </responsible_party>
  <keyword>peripheral vascular diseases</keyword>
  <keyword>Intermittent Claudication</keyword>
  <keyword>Angioplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Intermittent Claudication</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

